Literature DB >> 20587162

Evaluation of a commercial colorimetric fecal dipstick assay for the detection of Helicobacter hepaticus infections in laboratory mice.

Julie E Freebersyser1, Michael T Drake, Lela K Riley, Matthew H Myles, Robert S Livingston.   

Abstract

Mice used in biomedical research typically are tested for the presence of Helicobacter spp., including Helicobacter hepaticus. Here we evaluated the ability of a commercially available colorimetric Helicobacter dipstick assay to detect H. hepaticus in experimentally and naturally infected mice, with use of a Helicobacter PCR assay as the 'gold standard' test. None of the fecal samples from experimentally infected A/JCr mice (n = 12) tested positive for Helicobacter by the colorimetric dipstick test. In naturally infected A/JCr and C57BL/6 mice, 11% (1 of 9) and 30% (3 of 10) of fecal samples, respectively, tested positive for Helicobacter by the colorimetric dipstick assay. In these 3 groups of H. hepaticus-infected mice, statistically fewer mice tested positive by the colorimetric dipstick test than by PCR. The colorimetric Helicobacter dipstick assay had an overall diagnostic sensitivity of 13%, diagnostic specificity of 94%, and analytical sensitivity of 10(8) H. hepaticus cfu/mL. As currently formulated, the colorimetric dipstick assay had high specificity but lacked sensitivity for detecting H. hepaticus infections in 2 strains of mice commonly used in research, thereby limiting its utility as a diagnostic screening test for H. hepaticus infections in research mice.

Entities:  

Mesh:

Year:  2010        PMID: 20587162      PMCID: PMC2877303     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  14 in total

1.  Differential detection of five mouse-infecting helicobacter species by multiplex PCR.

Authors:  Sunlian Feng; Karin Ku; Emir Hodzic; Edward Lorenzana; Kim Freet; Stephen W Barthold
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

Review 2.  Detection, eradication, and research implications of Helicobacter infections in laboratory rodents.

Authors:  Mark T Whary; James G Fox
Journal:  Lab Anim (NY)       Date:  2006 Jul-Aug       Impact factor: 12.625

3.  Identification of enterohepatic Helicobacter species by restriction fragment-length polymorphism analysis of the 16S rRNA gene.

Authors:  Z Shen; Y Feng; J G Fox
Journal:  Helicobacter       Date:  2000-09       Impact factor: 5.753

4.  Pathogenicity of Helicobacter rodentium in A/JCr and SCID mice.

Authors:  Matthew H Myles; Robert S Livingston; Craig L Franklin
Journal:  Comp Med       Date:  2004-10       Impact factor: 0.982

5.  Identification of murine helicobacters by PCR and restriction enzyme analyses.

Authors:  L K Riley; C L Franklin; R R Hook; C Besch-Williford
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

Review 6.  Natural and experimental Helicobacter infections.

Authors:  Mark T Whary; James G Fox
Journal:  Comp Med       Date:  2004-04       Impact factor: 0.982

7.  Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.

Authors:  J M Ward; J G Fox; M R Anver; D C Haines; C V George; M J Collins; P L Gorelick; K Nagashima; M A Gonda; R V Gilden
Journal:  J Natl Cancer Inst       Date:  1994-08-17       Impact factor: 13.506

8.  Chronic active hepatitis in mice caused by Helicobacter hepaticus.

Authors:  J M Ward; M R Anver; D C Haines; R E Benveniste
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

9.  Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis.

Authors:  Matthew H Myles; Robert S Livingston; Beth A Livingston; Jennifer M Criley; Craig L Franklin
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  Diagnostic testing of mouse and rat colonies for infectious agents.

Authors:  Robert S Livingston; Lela K Riley
Journal:  Lab Anim (NY)       Date:  2003-05       Impact factor: 12.625

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.